Old Web
English
Sign In
Acemap
>
Paper
>
621PDPhase II trial of tepotinib vs sorafenib in Asian patients (pts) with advanced hepatocellular carcinoma (HCC)
621PDPhase II trial of tepotinib vs sorafenib in Asian patients (pts) with advanced hepatocellular carcinoma (HCC)
2018
B-Y Ryoo
Z Ren
T-Y Kim
Hongming Pan
K-M Rau
Hye Jin Choi
J-W Park
J H Kim
C-J Yen
B. H. Kim
D Zhou
Josef Straub
C Zhao
Shukui Qin
Keywords:
Gastroenterology
Pathology
Hepatocellular carcinoma
Phases of clinical research
Medicine
Sorafenib
Brachial Plexus Neuritis
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI
[]